4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine

C24H41NO — CID 139662735

IUPAC4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine
SMILESCC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CN1CCOCC1
InChIInChI=1S/C24H41NO/c1-21(2)9-6-10-22(3)11-7-12-23(4)13-8-14-24(5)15-16-25-17-19-26-20-18-25/h9,11,13,15H,6-8,10,12,14,16-20H2,1-5H3/b22-11+,23-13+,24-15+
InChIKeyGLHBHLXTTBQPSA-QMCSRMPWSA-N
MW359.60 g/mol
LogP6.46
Rot. Bonds11

About 4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine

4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine (PubChem CID 139662735) has the molecular formula C24H41NO and a molecular weight of 359.60 g/mol. Its IUPAC name is 4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine.

Molecular Properties

Compound Name4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine
PubChem CID139662735
Molecular FormulaC24H41NO
Molecular Weight359.60 g/mol
Exact Mass359.32
IUPAC Name4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine
SMILESCC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CN1CCOCC1
InChIInChI=1S/C24H41NO/c1-21(2)9-6-10-22(3)11-7-12-23(4)13-8-14-24(5)15-16-25-17-19-26-20-18-25/h9,11,13,15H,6-8,10,12,14,16-20H2,1-5H3/b22-11+,23-13+,24-15+
InChIKeyGLHBHLXTTBQPSA-QMCSRMPWSA-N
XLogP6.46
TPSA12.47 Ų
H-Bond Donors
H-Bond Acceptors2
Rotatable Bonds11
Heavy Atoms26
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500359.60
LogP ≤ 56.46
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 102

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3,7-dimethyl-N-(3-morpholin-4-ylpropyl)octa-2,6-dien-1-amine
CID 72671760
ST50979702
CID 5801574
Morpholine, 4-(3,7,11-trimethyl-2,6,10-dodecatrienyl)-
CID 6446852
(6Z)-3,7,11-trimethyl-N-(3-morpholin-4-ylpropyl)dodeca-2,6,10-trien-1-amine
CID 156020897
4-Icosa-5,8,11,14-tetraenylmorpholine
CID 49824013
1-Morpholyl-2,7-octadiene
CID 331750
4-[(2E)-2,5-dimethylhexa-2,5-dienyl]morpholine
CID 12485223
4-Pent-2-enylmorpholine
CID 68590211
(e)-4-(2-Methyl-6-methyleneocta-2,7-dien-1-yl)morpholine
CID 137797148
(z)-4-(2-Methyl-6-methyleneocta-2,7-dien-1-yl)morpholine
CID 137797149
4-[(2E)-3,7-dimethylocta-2,6-dienyl]morpholine
CID 11673016
4-[(2Z)-hept-2-en-1-yl]morpholine
CID 15266205

Frequently Asked Questions

What is the IUPAC name of 4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine?
The IUPAC name of 4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine (CID 139662735) is 4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine.
What is the SMILES notation for 4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine?
The canonical SMILES for 4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine is CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CN1CCOCC1.
What is the InChIKey of 4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine?
The InChIKey is GLHBHLXTTBQPSA-QMCSRMPWSA-N. The full InChI is InChI=1S/C24H41NO/c1-21(2)9-6-10-22(3)11-7-12-23(4)13-8-14-24(5)15-16-25-17-19-26-20-18-25/h9,11,13,15H,6-8,10,12,14,16-20H2,1-5H3/b22-11+,23-13+,24-15+.
What are the key properties of 4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine?
4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine has a molecular weight of 359.60 g/mol, XLogP of 6.46, 11 rotatable bonds, 0 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]morpholine is sourced from PubChem (CID 139662735), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).